Ischemic

3

Review clinical trials related to Ischemic. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis

An observational study to determine if individuals with increased platelet FcyRIIa will have a higher risk of ischemic events.

Participants needed: 250
Trial details
Age: 30+Biological sex: AllType: ObservationalSponsor: University of California, Los AngelesUpdated: Jun 11, 2026Locations: 1
Eligibility criteria

Stroke is defined as symptoms lasting >24 hours and associated with imaging evid... [+5]

Other determined etiology or established cause of the acute stroke or TIA: atria... [+1]

Status: Not yet recruiting

BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Atherosclerosis

This trial aims to compare the safety and efficacy of apixaban alone versus apixaban combined with clopidogrel in patients with acute ischemic stroke associated with non-valvular atrial fibrillation and concomitant symptomatic intracranial or extracranial atherosclerosis. Participants will be randomly assigned in a 1:1 ratio to receive apixaban monotherapy or dual therapy with clopidogrel for 30 days. The primary outcome is the incidence of symptomatic or asymptomatic recurrent ischemic lesions detected on brain MRI (DWI/FLAIR) at 30 ± 5 days after initiation of study medication.

Participants needed: 586
Trial details
Phase: Phase 4Age: 19+Biological sex: AllType: InterventionalSponsor: Yonsei UniversityUpdated: Nov 19, 2025
Eligibility criteria

Adults aged 19 years or older at the time of enrollment. [+3]

Presence of mechanical heart valves or rheumatic mitral stenosis. [+21]